We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current VIRI market cap is 4.24M. The company's latest EPS is USD -0.2750 and P/E is -0.80.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.56M | -1.48M | -1.27M | -1.14M | -1.31M |
| Net Income | -1.52M | -1.44M | -1.24M | -1.1M | -1.29M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.18M | -10.01M | -15.64M | -12.32M | -5.45M |
| Net Income | -2.47M | -10.35M | -15.96M | -12.25M | -5.3M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 6.52M | 5.21M | 5.25M | 4.17M | 3.23M |
| Total Liabilities | 550k | 520k | 487k | 358k | 570k |
| Total Equity | 5.97M | 4.69M | 4.76M | 3.81M | 2.66M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 316k | 31.47M | 15.78M | 8.37M | 4.17M |
| Total Liabilities | 5.26M | 1.53M | 1.28M | 1.04M | 358k |
| Total Equity | -5.02M | 29.94M | 14.5M | 7.33M | 3.81M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -1.7M | -2.44M | -3.4M | -4.87M | -937k |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | N/A | 1.16M | 1.16M | N/A |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -2.09M | -3.9M | -15.69M | -11.47M | -4.87M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 2.37M | 33.38M | -97k | 4.49M | 1.16M |
| Market Cap | 4.24M |
| Price to Earnings Ratio | -0.80 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.28 |
| Price to Book Ratio | 1.11 |
| Dividend Yield | - |
| Shares Outstanding | 19.26M |
| Average Volume (1 week) | 1.37M |
| Average Volume (1 Month) | 1.88M |
| 52 Week Change | -89.86% |
| 52 Week High | 2.18 |
| 52 Week Low | 0.1557 |
| Spread (Intraday) | 0.02 (9.09%) |
| Company Name | Virios Therapeutics Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.virios.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
